These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16079382)

  • 21. Expression and function of HD2-type histone deacetylases in Arabidopsis development.
    Zhou C; Labbe H; Sridha S; Wang L; Tian L; Latoszek-Green M; Yang Z; Brown D; Miki B; Wu K
    Plant J; 2004 Jun; 38(5):715-24. PubMed ID: 15144374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes.
    Huang Y; Myers SJ; Dingledine R
    Nat Neurosci; 1999 Oct; 2(10):867-72. PubMed ID: 10491605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective regulation of class I and class II histone deacetylases expression by inhibitors of histone deacetylases in cultured mouse neural cells.
    Ajamian F; Salminen A; Reeben M
    Neurosci Lett; 2004 Jul; 365(1):64-8. PubMed ID: 15234474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
    Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasion of v-Fos(FBR)-transformed cells is dependent upon histone deacetylase activity and suppression of histone deacetylase regulated genes.
    McGarry LC; Winnie JN; Ozanne BW
    Oncogene; 2004 Jul; 23(31):5284-92. PubMed ID: 15107823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MBP-1 physically associates with histone deacetylase for transcriptional repression.
    Ghosh AK; Steele R; Ray RB
    Biochem Biophys Res Commun; 1999 Jul; 260(2):405-9. PubMed ID: 10403782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics and comparative reactivity of human class I and class IIb histone deacetylases.
    Schultz BE; Misialek S; Wu J; Tang J; Conn MT; Tahilramani R; Wong L
    Biochemistry; 2004 Aug; 43(34):11083-91. PubMed ID: 15323567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation.
    Sinn DI; Kim SJ; Chu K; Jung KH; Lee ST; Song EC; Kim JM; Park DK; Kun Lee S; Kim M; Roh JK
    Neurobiol Dis; 2007 May; 26(2):464-72. PubMed ID: 17398106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer.
    Dressel U; Renkawitz R; Baniahmad A
    Anticancer Res; 2000; 20(2A):1017-22. PubMed ID: 10810390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proliferation and cellular death of A375 cell line in the presence of HDACs inhibitors.
    Chodurek E; Orchel A; Gawlik N; Kulczycka A; Gruchlik A; Dzierzewicz Z
    Acta Pol Pharm; 2010; 67(6):686-9. PubMed ID: 21229888
    [No Abstract]   [Full Text] [Related]  

  • 33. Targeting histone deacetylase 2 in chronic obstructive pulmonary disease treatment.
    Barnes PJ
    Expert Opin Ther Targets; 2005 Dec; 9(6):1111-21. PubMed ID: 16300464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of HDAC2 in the pathophysiology of COPD.
    Barnes PJ
    Annu Rev Physiol; 2009; 71():451-64. PubMed ID: 18817512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional regulation of cholesterol 24-hydroxylase by histone deacetylase inhibitors.
    Shafaati M; O'Driscoll R; Björkhem I; Meaney S
    Biochem Biophys Res Commun; 2009 Jan; 378(4):689-94. PubMed ID: 19059217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.
    Barnes PJ; Ito K; Adcock IM
    Lancet; 2004 Feb; 363(9410):731-3. PubMed ID: 15001333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3.
    Jung JW; Lee S; Seo MS; Park SB; Kurtz A; Kang SK; Kang KS
    Cell Mol Life Sci; 2010 Apr; 67(7):1165-76. PubMed ID: 20049504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2.
    Meja KK; Rajendrasozhan S; Adenuga D; Biswas SK; Sundar IK; Spooner G; Marwick JA; Chakravarty P; Fletcher D; Whittaker P; Megson IL; Kirkham PA; Rahman I
    Am J Respir Cell Mol Biol; 2008 Sep; 39(3):312-23. PubMed ID: 18421014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The discovery of histone deacetylase.
    Yao TP; Seto E
    Handb Exp Pharmacol; 2011; 206():v. PubMed ID: 22046630
    [No Abstract]   [Full Text] [Related]  

  • 40. Reduced histone deacetylase in COPD: clinical implications.
    Barnes PJ
    Chest; 2006 Jan; 129(1):151-5. PubMed ID: 16424426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.